NCT00449553 - Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. | Biotech Hunter

Enrollment

326

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Diabetes Mellitus

Interventions

DRUG

Pioglitazone and sulphonylurea

Pioglitazone 15 mg, tablets, orally, once daily and stable sulphonylurea therapy for up to 24 months.

DRUG

Pioglitazone and sulphonylurea

Pioglitazone 30 mg, tablets, orally, once daily and stable sulphonylurea therapy for up to 24 months.

DRUG

Pioglitazone and metformin

Pioglitazone 15 mg, tablets, orally, once daily and stable metformin therapy for up to 24 months.

DRUG

Pioglitazone and metformin

Pioglitazone 30 mg, tablets, orally, once daily and stable metformin therapy for up to 24 months.

Trial Locations (4)

Multiple